Drug reduces excess iron in ultra-rare neurodegenerative disease

被引：0
|
作者：
Sarah Lemprière
机构：
[1] Nature Reviews Neurology,
来源：
Nature Reviews Neurology | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：492 / 493
页数：1
相关论文
共 50 条
  • [41] Realizing the Potential of Gene Therapies for Rare and Ultra-Rare Inherited Diseases
    Booth, Claire
    Aiuti, Alessandro
    HUMAN GENE THERAPY, 2023, 34 (17-18) : 776 - 781
  • [42] Establishing a Novel Reimbursement Strategy for Drugs Developed for "Angel" Ultra-Rare Disease Patients
    Horgan, Richard
    Faulkner, Eric
    MOLECULAR THERAPY, 2024, 32 (04) : 652 - 653
  • [43] PBI-4050, a potential anti-fibrotic drug, improves liver fibrosis in Alstrom Syndrome, an ultra-rare disease
    Baig, S.
    Geberhiwot, T.
    Gagnon, L.
    Grouix, B.
    Laurin, P.
    Foulkes, L.
    Dorion, C.
    Cesari, F.
    Vaughan, O.
    Moran, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S108 - S108
  • [44] Economic burden and health related quality of life of ultra-rare Gaucher disease in China
    Qi, Xinye
    Xu, Jiao
    Shan, Linghan
    Li, Ye
    Cui, Yu
    Liu, Huan
    Wang, Kexin
    Gao, Lijun
    Kang, Zheng
    Wu, Qunhong
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [45] THE ROLE OF DELETERIOUS ULTRA-RARE VARIANTS IN ADHD RISK
    Demontis, Ditte
    Satterstrom, F. Kyle
    Duan, Jinjie
    Lescai, Francesco
    Ostergaard, Soren Dinesen
    Lesch, Klaus-Peter
    Werge, Thomas
    Mortensen, Preben Bo
    Glerup, Simon
    Franke, Barbara
    Hougaard, David
    Reif, Andreas
    Daly, Mark
    Neale, Benjamin
    Borglum, Anders
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1106 - 1106
  • [46] Economic burden and health related quality of life of ultra-rare Gaucher disease in China
    Xinye Qi
    Jiao Xu
    Linghan Shan
    Ye Li
    Yu Cui
    Huan Liu
    Kexin Wang
    Lijun Gao
    Zheng Kang
    Qunhong Wu
    Orphanet Journal of Rare Diseases, 16
  • [47] ANALYSIS OF THE PREVALENCE OF DISEASE AREAS IN THE GENE THERAPY PIPELINE: FROM ULTRA-RARE TO PREVALENT
    Orchard, M.
    Alderson, D.
    VALUE IN HEALTH, 2022, 25 (01) : S131 - S131
  • [48] ECONOMIC MODEL FOR A GENE THERAPY IN AN ULTRA-RARE DISEASE: EXPERT VALIDATION OF APPROACH AND ASSUMPTIONS
    Sopena, L.
    Simons, C.
    Mumford, A.
    Bennison, C.
    Irvin, W.
    Paris, J. J.
    Buesch, K.
    VALUE IN HEALTH, 2022, 25 (01) : S79 - S79
  • [49] Ultra-rare mutations in &ITSRCAP&IT segregate in Caribbean Hispanic families with Alzheimer disease
    Vardarajan, Badri N.
    Tosto, Giuseppe
    Lefort, Roger
    Yu, Lei
    Bennett, David A.
    De Jager, Philip L.
    Barral, Sandra
    Reyes-Dumeyer, Dolly
    Nagy, Peter L.
    Lee, Joseph H.
    Cheng, Rong
    Medrano, Martin
    Lantigua, Rafael
    Rogaeva, Ekaterina
    St George-Hyslop, Peter
    Mayeux, Richard
    NEUROLOGY-GENETICS, 2017, 3 (05)
  • [50] Gene-disease relationship evidence: A clinical perspective focusing on ultra-rare diseases
    Santen, Gijs W. E.
    Leitch, Harry G.
    Cobben, Jan
    HUMAN MUTATION, 2022, 43 (08) : 1082 - 1088
12345